Editorial - Interventional Cardiology (2024)
Values of wire-based coronary physiology assessment in coronary interventional procedures
- Corresponding Author:
- Randa Salah Gomaa Mahmoud
Department of medical physiology, Faculty of human medicine, Zagazig University, Zagazig, Egypt,
E-mail: rsgomaa@medicine.zu.edu.eg
Received date: 26-May-2024, Manuscript No. FMIC-24-137281; Editor assigned: 28-May-2024, PreQC No. FMIC-24-137281 (PQ); Reviewed date: 12-Jun-2024, QC No. FMIC-24-137281; Revised date: 19-Jun-2024, Manuscript No. FMIC-24-137281 (R); Published date: 26-Jun-2024, DOI: 10.37532/1755-5310.2024.16(S23).595
Editorial
Ischemic heart disease is a globally leading factor of morbidity and mortality, and angina is the most prevalent symptom. A comprehensive history and examination are essential to recognize patients suffering from acute coronary syndrome. Coronary Artery Disease (CAD) is characterized by atherosclerosis developing in the epicardial vessels, which may be obstructive or non-obstructive. Several basic tests can be completed in patients with suspected CAD, such as bio-chemical testing, a resting electrocardiogram, resting echocardiography, and, in selected cases, ambulatory Electrocardiogram (ECG) monitoring [1].
Physiologic assessment of coronary artery disease plays an important role in guiding the decision to proceed with Percutaneous Coronary Intervention (PCI), bypass surgery, or revascularization delay [2]. The validity of coronary physiology assessment and superior clinical outcomes with physiology-guided PCI compared with angiography guided PCI have been practically established by randomized trials [3,4].
Percutaneous or surgical coronary revascularization aims to recover coronary flow and alleviate myocardial ischemia. The decision-making process in patients with Coronary Artery Disease (CAD) remains largely based on Invasive Coronary Angiography (ICA), however, ICA could not assess the functional significance of coronary artery stenoses [5].
The use of invasive physiological lesion assessment to guide coronary revascularization has been well established in various studies [6-8], has been implemented in guidelines [9], and is increasing in use in clinical practice [10].
Intracoronary physiological assessment is recognized as a valued approach to detect the presence of flow-limiting epicardial stenoses in patients with Chronic Coronary Syndromes (CCS) and to determine an indication for Percutaneous Coronary Interventions (PCI) [11].
The most frequently used index to determine the hemodynamic significance of coronary stenosis is Fractional Flow Reserve (FFR), invasive coronary physiology measurements with coronary guidewires with a pressure sensor, which is defined as the maximum achievable blood flow to a myocardial territory in the presence of a stenosis as a ratio to the normal maximum achievable blood flow to that same myocardial territory in the hypothetical situation the supplying vessel would be completely normal [12]. FFR is the ratio of the pressure measured by the pressure wire distal to a lesion to that measured proximally from the guiding catheter, over the entire cardiac cycle, during hyperemia. Hyperemia is induced by either an intravenous infusion of adenosine at 140μg/kg/min via a central vein (but in routine practice by a large, proximal, peripheral vein) or by an intracoronary bolus of adenosine through the guiding catheter (40μg right and 80 μg left coronary artery) [13].
Recently, it was proved that in patients with acute myocardial infarction and multi-vessel coronary disease, a strategy of selective PCI using FFR-guided decision-making was superior to a strategy of routine PCI based on angiographic diameter stenosis for treatment of non-infarct-related artery lesions regarding the risk of death, MI, or repeat revascularization [14,15].
On the other hand, a suboptimal physiologic result is observed after PCI, even in the context of physiology-driven revascularization [16]. This suboptimal result may be avoided in some cases by optimal selection of the lesion that can expect to get sufficient post-PCI physiologic gain. Suboptimal interventional procedure itself can be the reason for a suboptimal physiologic result. In this regard, additional procedures guided by post-PCI physiologic assessment can further improve the results [17]. The FFRSEARCH (Fractional Flow Reserve-Stent Evaluated at Rotterdam Cardiology Hospital) study described potential mechanisms for a suboptimal post-PCI FFR using Intravascular Ultrasound (IVUS) [18]. In addition, in the TARGET-FFR trial, the percentage of patients with the suboptimal post-PCI result (FFR<0.80) decreased significantly by applying the additional PCI procedure compared to the conservative group. However, the additional PCI procedure failed to increase the percentage of the patients who achieved the target post-PCI FFR (>0.90) compared to the conservative group.
Recently, the instantaneous wave-Free Ratio (iFR) is defined as the ratio of resting distal coronary pressure to proximal coronary pressure during a specific part of cardiac diastole, termed the Wave-Free Period (WFP) of when blood flow is at its highest [19]. iFR is a Non-Hyperemic Pressure Ratio (NHPR) that does not require vasodilator administration for maximal hyperemia, so it is quicker to measure in comparison with FFR and prevents patient exposure to side effects of potent vasodilators, which compromises the patient and may simplify physiological assessments in routine clinical practice [20].
Moreover, iFR has been shown to correlate well with noninvasive ischemia testing [21], and to be non-inferior to FFR in guiding revascularization decisions in patients with intermediate Coronary Artery Disease (CAD) in 2 large randomized clinical trials that are iFRSWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome) trial [22], and DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularization) trial [23].
A reliable and proven technique called Computed Tomography- Based FFR (FFR CT) can effectively model FFR in the major coronary vessels using computed tomography [24]. This technique can evaluate atheroma magnitude, pattern, and presence, along with vessel-specific ischemia by creating an anatomical model of the arteries and a physiological model of the circulation process. Resting coronary flow is calculated based on myocardial mass, the maximum hyperemia is estimated by considering the expected reduction in resistance with adenosine injection and the FFR CT is then measured using supercomputers and computational fluid dynamics methods.
FFR CT provides additional anatomical information within physiological assessment, lowering the number of invasive coronary angiography exams and the need for invasive FFR measurement, a cost-efficient method, and non-inferiority compared with invasive FFR. Several studies confirm the reliability of this noninvasive assessment for stable angina patients, like PACIFIC [25], ADVANCE [26], and TARGET [27] trials.
FFR CT can help in assessing and treating patients with positive clinical outcomes while decreasing the need for invasive angiography. So, it is reasonable to assume that routinely investigating the anatomy and physiology of all epicardial coronary arteries would lead to better diagnostic outcomes [1].
In conclusion, invasive physiological assessment including the physiological indices has become an important component of patient assessment in the cardiac catheterization laboratory. These strategies enhance our information on IHD, and how it is best treated. However, FFRCT is a noninvasive technique with low risk of adverse events and holds clinical potential to provide anatomic and hemodynamic significance of coronary lesions.
References
- Chioncel V, Gherasie FA. The role of coronary physiology assessment in the diagnosis and treatment of stable angina. Dive inside recent findings of diffuse coronary disease treatment. Rev Cardiovasc Med. 25(3):108 (2024).
- Misumida N, Moliterno DJ. Coronary physiology assessment: On becoming faster, friendlier, and a better guiding companion. JACC: Asia. 3(6):843-845 (2023).
- Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study: Fractional flow reserve versus angiography in multi-vessel evaluation. J Am Coll Cardiol. 55(25):2816-2821 (2010).
- Kogame N, Ono M, Kawashima H, et al. The impact of coronary physiology on contemporary clinical decision making. JACC Cardiovasc Interv. 13(14):1617-1638 (2020).
- Fezzi S, Huang J, Lunardi M, et al. Coronary physiology in the catheterisation laboratory: An A to Z practical guide. AsiaIntervention. 8(2):86 (2022).
- De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 367(11):991-1001 (2012).
- Xaplanteris P, Fournier S, Pijls NH, et al. Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med. 379(3):250-259 (2018).
- Bundhun PK, Gupta C, Huang F, et al. Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: A meta-analysis. Medicine.96(46):e8748 (2017).
- Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology appropriate use criteria task force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeon. J Am Coll Cardiol. 69(17):2212-2241 (2017).
- Jeremias A, Davies JE, Maehara A, et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary intervention: The DEFINE PCI study. JACC Cardiovasc Interv.12(20):1991-2001 (2019).
- Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 41(3):407-477 (2020).
- Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 360(3):213-224 (2009).
- Morris PD, Al-Lamee RK, Berry C, et al. Coronary physiological assessment in the catheter laboratory: Haemodynamics, clinical assessment and future perspectives. Heart.108(21):1737-1746 (2022).
- Lee JM, Kim HK, Park KH, et al. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multi-vessel disease: A randomized trial. Eur Heart J.44(6):473-484 (2023).
- Lee JM, Kim HK, Park KH, et al. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multi-vessel disease: A randomized trial. Eur Heart J. 44(6):473-484 (2023).
- Collison D, Didagelos M, Aetesam-ur-Rahman M, et al. Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR). Eur Heart J. 42(45):4656-4668 (2021).
- Koo BK, Lee JM, Hwang D, et al. Practical application of coronary physiologic assessment: Asia-pacific expert consensus document: Part 1. JACC: Asia. 3(5):689-706 (2023).
- van Zandvoort LJ, Masdjedi K, Witberg K, et al. Explanation of post-procedural fractional flow reserve below 0.85: A comprehensive ultrasound analysis of the FFR SEARCH registry. Circ Cardiovasc Interv. 12(2):e007030 (2019).
- Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: Results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 59(15):1392-1402 (2012).
- van de Hoef TP. Synopsis of clinical coronary physiology. 2018:517-542 (2018).
- Hwang D, Jeon KH, Lee JM, et al. Diagnostic performance of resting and hyperemic invasive physiological indices to define myocardial ischemia: Validation with 13N-ammonia positron emission tomography. JACC Cardiovasc Interv.10(8):751-760 (2017).
- Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 376(19):1813-1823 (2017).
[CrossRef][Google Scholar][PubMed]
- Davies JE, Sen S, Dehbi HM, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 376(19):1824-1834 (2017).
- Chen J, Wetzel LH, Pope KL, et al. FFRCT: Current status. AJR Am J Roentgenol. 216(3):640-648 (2021).
- Driessen RS, Danad I, Stuijfzand WJ, et al. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. J Am Coll Cardiol. 73(2):161-173 (2019).
- Fairbairn TA, Nieman K, Akasaka T, et al. Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: Lessons from the ADVANCE Registry. Eur Heart J. 39(41):3701-3711 (2018).
- Yang J, Shan D, Wang X, et al. On-site computed tomography-derived fractional flow reserve to guide management of patients with stable coronary artery disease: The TARGET randomized trial. Circulation. 147(18):1369-1381 (2023).